Physician profile
Roz Nanda
NPI 1043380678
$4,810.78
in general payments reported to CMS, 2019-2025
40 companies · $331 in 2025
The $331 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $712 · 2020: $635 · 2021: $1,069 · 2022: $692 · 2023: $732 · 2024: $640 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,689 · Entertainment: $13.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,688.90 |
| Entertainment | $13.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,090.12 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $438.83 | 2023-2025 | Myfembree |
| Evofem Biosciences, INC. | $403.17 | 2021-2025 | Phexxi, Solosec, Phexx |
| Mayne Pharma Commercial LLC | $334.33 | 2021-2025 | |
| Novo Nordisk INC | $327.69 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Baxter Healthcare | $214.72 | 2021-2024 | Perclot, Floseal |
| Exeltis, USA INC. | $214.44 | 2019-2025 | Slynd, Tyblume |
| Myovant Sciences INC. | $207.87 | 2021-2022 | |
| Lupin INC. | $150.01 | 2019-2021 | |
| Hologic Sales and Service, LLC | $141.04 | 2019-2024 | Acessa Provu System, Aptima, Myosure Tissue Removal Device |
| Agile Therapeutics, INC. | $124.21 | 2021-2023 | Twirla |
| Shield Therapeutics INC | $122.56 | 2023-2025 | Accrufer |
| Millicent US INC | $107.22 | 2020-2025 | Intrarosa, Femlyv, Femring |
| Allergan, INC. | $87.48 | 2019-2020 | |
| Avion Pharmaceuticals | $82.62 | 2019-2023 | Balcoltra |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $78.72 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $77.67 | 2019-2023 | Gardasil 9 |
| Pfizer INC. | $60.02 | 2024 | |
| Organon LLC | $58.74 | 2021-2025 | Jada System |
| Pacira Pharmaceuticals Incorporated | $40.01 | 2019-2021 | |
| Coopersurgical, INC. | $39.63 | 2019-2023 | Endosee, Advincula Delineator Uterine Manipulator |
| Gynesonics, INC. | $36.73 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Aspira Women'S Health INC | $36.70 | 2020-2024 | Ova1 |
| Lilly USA, LLC | $31.92 | 2020-2024 | Jardiance, Zepbound |
| Genentech USA, INC. | $28.46 | 2020 | |
| Medicem INC. | $26.93 | 2020-2021 | |
| Meditrina | $24.40 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $23.71 | 2023 | Vivjoa |
| Dilon Technologies, INC. | $22.35 | 2025 | Hemoblast Bellows |
| Olympus America INC. | $22.23 | 2019 | |
| Daiichi Sankyo INC. | $21.56 | 2021 | |
| Avanos Medical | $18.37 | 2021 | |
| Vertical Pharmaceuticals, LLC | $17.34 | 2019 | |
| Ethicon US, LLC | $15.67 | 2019 | |
| Optumhealth Care Solutions, LLC | $15.18 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Kesin Pharma Corporation | $15.00 | 2023 | Likmez |
| Argentum Medical | $13.54 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $13.47 | 2019 | |
| Innovation Technologies INC | $13.13 | 2024 | Irrisept |
| Scynexis, INC. | $12.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roz Nanda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.